Trastuzumab biosimilar (Bionovis/The Instituto Vital Brazil)
曲妥珠单抗生物类似药 (Bionovis/The Instituto Vital Brazil)
Report date: 2022/01/14 13:23:58
Base Information
Drug NameTrastuzumab biosimilar (Bionovis/The Instituto Vital Brazil)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesBionovisThe Instituto Vital Brazil
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesBionovisThe Instituto Vital Brazil
Active IndicationsN/A
Inactive Indications
Other Information
ATC Code
Related LinksN/A